Financial Year |
March 31 2023 |
Monetary Funds |
512,796,940.42 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
342,278.35 |
Accounts Receivable |
987,033,714.86 |
Advances to Suppliers |
46,199,517.37 |
Other Receivables |
73,221,754.08 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
740,193,526.60 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
883,528,868.40 |
Other Current Assets |
130,204,142.48 |
Total Current Assets |
3,434,679,084.19 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
248,072,475.07 |
Investment Properties |
319,158,400.00 |
Fixed Assetes |
2,115,508,702.74 |
Under-construction Projects |
657,756,974.03 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
97,215,539.75 |
R&D expenses |
-- |
Goodwill |
29,089,520.14 |
Long-Term Deferred and Prepaid Expenses |
158,289,266.93 |
Deferred Income Tax Assets |
332,921,677.58 |
Other Non-Current Assets |
84,021,697.59 |
Sub-Total of Non-Current Assets |
4,631,302,573.79 |
Total Assets |
8,065,981,657.98 |
Short-Term Loans |
1,865,687,608.29 |
Trading Financial liabilities |
-- |
Notes Payable |
41,660,437.10 |
Accounts Payable |
1,412,762,459.32 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
68,884,627.79 |
Taxes Payable |
11,664,607.83 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
39,558,452.88 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
268,989,555.83 |
Other Current Liabilities |
3,414,688.36 |
Sub-Total of Current Liabilities |
3,736,653,987.21 |
Long-term Loans |
49,800,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
126,349,339.14 |
Total Liabilities |
3,863,003,326.35 |
Paid-In Capital(Or Share Stock) |
3,441,517,719.00 |
Capital Surplus |
3,760,156,450.80 |
Surplus Reserve |
84,091,441.57 |
LESS:Treasury Stock |
61,740,082.50 |
Undistributed Profits |
-3,056,310,570.89 |
Minority Stockholder's Interest |
-9,807,024.35 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,212,785,355.98 |
Owner's Equity(Stockholder's Equity) |
4,202,978,331.63 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
8,065,981,657.98 |